Summary
The use of primary (nontransformed) bone cell cultures is hampered by their cellular heterogeneity. Primary cultures of osteoblast-like cells have been shown to proliferate in response to several osteotropic agents, but because mixed cell populations are present it is uncertain whether a true osteoblastic response was observed. By combining (1) localization of [3H]-thymidine incorporation into the nuclei of actively dividing cells by autoradiography with (2) subsequent induction of osteoblast differentiation by 1,25(OH)2D3 to optimize the number of cells expressing high alkaline phosphatase activity and (3) its localization by histochemical staining, it is possible to measure the proliferation of cells that are capable of expressing a more mature osteoblastic phenotype in heterogeneous human trabecular bone cell cultures.
Over a 72-hour incubation period, rhIL-1α (0.2–2 ng/ml) exerted a dose-dependent stimulation of proliferation of cells expressing alkaline phosphatase. Purified human TGFβ1 produced a biphasic increase in the proliferation of these cells (0.01–1 ng/ml) but 17β and 17α-estradiol (10-12–10-8 M) failed to consistently regulate cell growth. Furthermore, 17β-estradiol did not reproducibly modulate proliferation induced by IL-1α or TGFβ when added together in cultures. This procedure represents a more accurate method for the assessment of osteoblast proliferation in primary bone cell cultures and demonstrates that estrogen is not mitogenic for human osteoblasts and does not potentiate the actions of putative local stimulators of osteoblast replication.
Similar content being viewed by others
References
Nilas E, Christiansen C (1987) Bone mass and its relationship to age and the menopause. J Clin Endocrinol Metab 65:697–702
Takano-Yamamoto T, Rodan GA (1990) Direct effects of 17β-estradiol on trabecular bone in ovariectomized rats. Proc Natl Acad Sci USA 87:2172–2176
Moore M, Bracker M, Sartoris D, Saltman P, Strause L (1990) Long-term estrogen replacement therapy in postmenopausal women sustains vertebral bone mineral density. J Bone Miner Res 5:659–664
Raisz LG (1988) Local and systemic factors in the pathogenesis of osteoporosis. N Engl J Med 318:818–828
Komm BS, Terpening CM, Benz DJ, Graeme KA, Gallegos A, Korc M, Greene GL, O'Malley BW, Haussler MR (1988) Estrogen binding, receptor messenger RNA, and biologic response in osteoblast-like cells. Science 241:81–84
Eriksen EF, Colvard DS, Berg NJ, Graham ML, Mann KG, Spelsberg TC, Riggs BL (1988) Evidence of estrogen receptors in normal human osteoblast-like cells. Science 241:84–86
Ernst M, Heath JK, Rodan GA (1989) Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor-1, and parathyroid hormone-stimulated adenylate cyclase activity in osteoblast-like cells from calvariae and long bones. Endocrinology 125:825–833
Gray TK, Flynn TC, Gray KM, Nabell LM (1987) 17β-estradiol acts directly on the clonal osteoblastic cell line UMR 106. Proc Natl Acad Sci USA 84:6267–6271
Vorderstrasse B, Wiren K (1990) Estrogen regulation of collagen gene expression in UMR 106-01 cells (abstract). J Bone Miner Res 5 (suppl 2):S218
Lee KL, Waye M, Wrana J, Aubin JE, Heersche JNM (1989) The effects of estrogen and interleukin 1 on TGFβ, osteopontin, collagen, and osteocalcin mRNA expression in osteoblast-like cells (abstract). J Bone Miner Res 4 (suppl 1): S152
Colvard D, Keeting P, Scott R, Spelsberg TC, Riggs BL (1989) Effects of estrogen on growth and differentiation of normal human osteoblast-like cells (abstract). J Bone Miner Res 4 (suppl 1):S118
Oursler MJ, Cortese C, Keeting P, Anderson MA, Bonde SK, Riggs BL, Spelsberg TC (1991) Modulation of transforming growth factor-β production in normal human osteoblast-like cells by 17β-estradiol and parathyroid hormone. Endocrinology 129:3313–3320
Keeting PE, Scott RE, Colvard DS, Han IK, Spelsberg TC, Riggs BL (1991) Lack of a direct effect of estrogen on proliferation and differentiation of normal human osteoblast-like cells. J Bone Miner Res 6:297–304
MacDonald BR, Gallagher JA, Russell RGG (1986) Parathyroid hormone stimulates the proliferation of cells derived from human bone. Endocrinology 118:2445–2449
Gowen M, MacDonald BR, Russell RGG (1988) Actions of recombinant human IFN-γ and TNFα on the proliferation and osteoblastic characteristics of human trabecular bone cells in vitro. Arthritis Rheum 31:1500–1508
Gowen M, Wood DD, Russell RGG (1985) Stimulation of the proliferation of human bone cells in vitro by human monocyte products with IL-1 activity. J Clin Invest 75:1223–1229
Evans DB, Bunning RAD, Russell RGG (1989) The effects of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) on human osteoblast-like cells. Biochem Biophys Res Commun 160:588–595
Beresford JN, Gallagher JA, Poser JW, Russell RGG (1984) Production of osteocalcin by human bone cells in vitro. Effects of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, parathyroid hormone and glucocorticoids. Metab Bone Dis Rel Res 5:229–234
Beresford JN, Gallagher JA, Russell RGG (1986) 1,25-dihydroxyvitamin D3 and human bone-derived cells in vitro: effects on alkaline phosphatase, type I collagen and proliferation. Endocrinology 119:1776–1785
Fedarko NS, Bianco P, Verner U, Robey PG (1990) Human bone cell enzyme expression and cellular heterogeneity: correlation of alkaline phosphatase enzyme activity with cell cycle. J Cell Physiol 144:115–121
Turksen K, Aubin JE (1991) Positive and negative immunoselection for enrichment of two classes of osteoprogenitor cells. J Cell Biol 114:373–384
Owen TA, Aronow M, Shalhoub V, Barone LM, Wilming L, Tassinari MS, Kennedy MB, Pockwinse S, Lian JB, Stein GS (1990) Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 143:420–430
Evans DB, Bunning RAD, Van Damme J, Russell RGG (1989) Natural human IL-1β exhibits regulatory actions on human bone-derived cells in vitro. Biochem Biophys Res Commun 159: 1242–1248
Boyce BF, Aufdemorte TB, Garrett IR, Yates AJP, Mundy GR (1989) Effects of interleukin I on bone turnover in normal mice. Endocrinology 125:1142–1150
Gowen M, Wood DD, Ihrie EJ, McGuire MKB, Russell RGG (1983) An interleukin I-like factor stimulates bone resorption in vitro. Nature 306:378–380
Pfeilschifter J, Chenu C, Bird A, Mundy GR, Roodman GD (1989) Interleukin 1 and tumour necrosis factor stimulate the formation of human osteoclast-like cells in vitro. J Bone Miner Res 4:113–118
Keeting PE, Rifas L, Harris SA, Colvard DS, Spelsberg TC, Peck WA, Riggs BL (1991) Evidence for interleukin 1β production by cultured normal human osteoblast-like cells. J Bone Miner Res 6:827–833
Wergedal JE, Matsuyama T, Strong DD (1992) Differentiation of normal human bone cells by transforming growth factor-β and 1,25(OH)2 vitamin D3. Metabolism 41:42–48
Bonewald LF, Kester MB, Schwartz Z, Swain LD, Khare A, Johnson TL, Leach RJ, Boyan BD (1992) Effects of combining transforming growth factor β and 1,25-dihydroxyvitamin D3 on differentiation of a human osteosarcoma (MG-63). J Biol Chem 267:8943–8949
Centrella M, McCarthy TL, Canalis E (1987) Transforming growth factor-β is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from foetal rat bone. J Biol Chem 262:2869–2874
Robey PG, Young MF, Flanders KC, Roche NS, Kondaiah P, Reddi AH, Termine JD, Sporn MB, Roberts AB (1987) Osteoblasts synthesize and respond to transforming growth factor-type β (TGFβ) in vitro. J Cell Biol 105:457–463
Centrella M, Massague J, Canalis E (1986) Human plateletderived transforming growth factor-β stimulates parameters of bone growth in foetal rat calvariae. Endocrinology 119:2306–2312
Chenu C, Pfeilschifter J, Mundy GR, Roodman GD (1988) Transforming growth factor-β inhibits formation of osteoclast-like cells in long-term human marrow cultures. Proc Natl Acad Sci USA 85:5683–5687
Oreffo ROC, Bonewald J, Kukita A, Garrett IR, Seyedin SM, Rosen D, Mundy GR (1990) Inhibitory effects of the bone-derived growth factors osteoinductive factor and transforming growth factor-β on isolated osteoclasts. Endocrinology 126:3069–3075
VandePol C, Schlaeger D, Wong GL (1989) Mitogenic responses to and binding of insulin-like growth factor 1 and/or epidermal growth factor by bone cells. Bone Miner 5:371–382
Kasperk CH, Fitzsimmons RJ, Strong DD, Wergedal JE, Baylink DJ (1990) Androgens increase bone cell proliferation and differentiation by mechanisms involving increased elaboration of and increased sensitivity to growth factors (abstract). J Bone Miner Res 5 (suppl 2):S84
Kurose H, Seino Y, Yamaoka K, Tanaka H, Shima M, Yabuuchi H (1989) Cooperation of synthetic insulin-like growth factor 1/somatomedin C and 1,25-dihydroxyvitamin D on regulation of function in clonal osteoblastic cells. Bone Miner 5:335–345
Takuwa Y, Ohse C, Wang EA, Wozney JM, Yamashita K (1991) Bone morphogenetic protein-2 stimulates alkaline phosphatase activity and collagen synthesis in cultured osteoblastic cells, MC3T3-E1. Biochem Biophys Res Commun 174:96–101
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rickard, D.J., Gowen, M. & MacDonald, B.R. Proliferative responses to estradiol, IL-1α and TGFβ by cells expressing alkaline phosphatase in human osteoblast-like cell cultures. Calcif Tissue Int 52, 227–233 (1993). https://doi.org/10.1007/BF00298724
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00298724